Overview
This case study covers my role as the Design lead in developing new features concepts for Lumii, an at-home digital health app that empowers people living with Myasthenia Gravis (MG) to actively manage their disease. MG is an autoimmune disorder that causes weakness and fatigue in the muscles. This 20-week project, funded by UCB, was specifically designed to address the unmet needs of MG healthcare professionals (HCP) in assessing and treating MG patients in a clinical setting.
In addition to the support of UCB, we had the amazing opportunity to partner with a leader in neurology and rare neuromuscular disease research, Professor Sabrina Sacconi, and her team at CHU Nice (Centre Hospitalier Universitaire de Nice). As a result, we proposed four new feature concepts to be further developed and implemented (by a 3rd party production partner).
--
UCB is a multinational biopharma company that focuses on creating meaningful solutions and delivering medicines to people living with neurological and autoimmune conditions. UCB is uncompromisingly patient-centric.